Common Contracts
3 similar Common Stock Purchase Agreement contracts by Peregrine Pharmaceuticals Inc
PEREGRINE PHARMACEUTICALS, INC. COMMON STOCK PURCHASE AGREEMENT 9,285,714 SHARES OF COMMON STOCK June 16, 2006Common Stock Purchase Agreement • June 19th, 2006 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
This Common Stock Purchase Agreement (this “Agreement”) is made and entered into as of June 16, 2006 (the “Effective Date”), by and between Peregrine Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Double U Master Fund LP (the “Investor”).
PEREGRINE PHARMACEUTICALS, INC. COMMON STOCK PURCHASE AGREEMENT 4,000,000 SHARES OF COMMON STOCK APRIL 5, 2006Common Stock Purchase Agreement • April 6th, 2006 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
This Common Stock Purchase Agreement (this “Agreement”) is made and entered into as of April 5, 2006 (the “Effective Date”), by and between Peregrine Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Double U Master Fund LP (the “Investor”).
PEREGRINE PHARMACEUTICALS, INC. COMMON STOCK PURCHASE AGREEMENT 8,000,000 SHARES OF COMMON STOCK JUNE 22, 2005Common Stock Purchase Agreement • June 24th, 2005 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
This Common Stock Purchase Agreement (this “Agreement”) is made and entered into as of June 22, 2005 (the “Effective Date”), by and between Peregrine Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Double U Master Fund LP (the “Investor”).
